Moxetumomab pasudotox-tdfk Intravenous and Mycophenolate sodium
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Mycophenolate sodium and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: mycophenolic acid
Brand name: Myfortic
Synonyms: Mycophenolic acid, Mycophenolate Tablets Delayed Release
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Mycophenolate Suspension
- Moxetumomab pasudotox-tdfk Intravenous-Mycophenolate Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Mycophenolate Tablets Delayed Release
- Moxetumomab pasudotox-tdfk Intravenous-Mycophenolic acid
- Moxetumomab pasudotox-tdfk Intravenous-Mycophenolic Acid Delayed-Release Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Mycophenolic Acid Tablets
- Mycophenolate sodium-Moxifloxacin
- Mycophenolate sodium-Moxifloxacin (Systemic)
- Mycophenolate sodium-Moxifloxacin Hydrochloride
- Mycophenolate sodium-Moxifloxacin Injection
- Mycophenolate sodium-Moxifloxacin Intravenous
- Mycophenolate sodium-Moxifloxacin Tablets